CTS-1027

DRUG4 trials

Sponsors

Conatus Pharmaceuticals Inc.

Conditions

Chronic Hepatitis C Virus InfectionHepatitis C

Phase 2

Study of CTS-1027 in Hepatitis C Patients

CompletedNCT00570336

Conatus Pharmaceuticals Inc.Chronic Hepatitis C Virus Infection

Start: 2007-12-31End: 2009-07-31Updated: 2010-09-16

CTS-1027 in Interferon-Naive Hepatitis C Patients

CompletedNCT00925990

Conatus Pharmaceuticals Inc.Hepatitis C

Start: 2009-06-30End: 2010-07-31Updated: 2012-03-27

Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders

CompletedNCT01051921

Conatus Pharmaceuticals Inc.Hepatitis C

Start: 2010-01-31End: 2011-12-31Updated: 2012-04-16

Standard of Care (SOC) With or Without CTS-1027 in Hepatitis C (HCV) Null-Responders

TerminatedNCT01273064

Conatus Pharmaceuticals Inc.Hepatitis C

Start: 2011-01-31End: 2011-10-31Updated: 2012-06-11